|
KIAA0892 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.278200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.024330E-03 |
| Normal-vs-Stage2 |
3.346000E-01 |
| Normal-vs-Stage3 |
4.921400E-01 |
| Normal-vs-Stage4 |
3.207600E-02 |
| Stage1-vs-Stage2 |
3.783400E-01 |
| Stage1-vs-Stage3 |
1.672410E-01 |
| Stage1-vs-Stage4 |
4.095600E-01 |
| Stage2-vs-Stage3 |
7.814400E-01 |
| Stage2-vs-Stage4 |
1.867050E-01 |
| Stage3-vs-Stage4 |
1.221790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.875500E-03 |
| Normal-vs-AfricanAmerican |
9.333900E-02 |
| Normal-vs-Asian |
9.976200E-01 |
| Caucasian-vs-AfricanAmerican |
6.063200E-01 |
| Caucasian-vs-Asian |
3.855400E-01 |
| AfricanAmerican-vs-Asian |
5.495200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.078740E-03 |
| Normal-vs-Female |
6.934000E-01 |
| Male-vs-Female |
3.871700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.578200E-02 |
| Normal-vs-Extreme_Weight |
2.217800E-04 |
| Normal-vs-Obese |
3.266000E-01 |
| Normal-vs-Extreme_Obese |
9.284400E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.456800E-01 |
| Normal_Weight-vs-Obese |
2.730400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.679200E-01 |
| Extreme_Weight-vs-Obese |
2.798500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.779600E-01 |
| Obese-vs-Extreme_Obese |
2.743200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.723200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.357200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.763540E-04 |
| Normal-vs-Age(81-100Yrs) |
2.004400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.694400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.404400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.025910E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.502800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.268000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.367400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.501600E-02 |
| Normal-VS-Type2 PRCC |
2.0618999999944E-05 |
| Normal-VS-KIRP CIMP |
4.826600E-01 |
| Normal-VS-Unclassified PRCC |
5.729800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.700300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.565800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.317000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.221600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.134050E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.243200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.480400E-03 |
| Normal-vs-N1 |
6.653400E-01 |
| Normal-vs-N2 |
3.652000E-02 |
| N0-vs-N1 |
2.380200E-01 |
| N0-vs-N2 |
6.379600E-01 |
| N1-vs-N2 |
3.985600E-01 |
|
|
